Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Roux

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Revue De Synthese|August 2, 2012
[Not Available]Sophie Roux
Joint Bone Spine|February 21, 2006
RANKL inhibitors: a bright future?Sophie Roux
Joint Bone Spine|April 13, 2010
New treatment targets in osteoporosisSophie Roux
Leukemia & Lymphoma|September 14, 2004
The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expressionSophie Roux, Xavier Mariette
International Journal of Molecular Sciences|October 21, 2020
Rab GTPases in Osteoclastic Bone Resorption and AutophagyMichèle Roy, Sophie Roux
Journal of Molecular Signaling|January 6, 2012
The adaptor protein p62/SQSTM1 in osteoclast signaling pathwaysStephen McManus, Sophie Roux
Biomed Research International|September 7, 2018
Rab GTPases in Osteoclastic Endomembrane SystemsMichèle Roy, Sophie Roux
The Lancet. Oncology|June 5, 2010
RANK and RANKL expression in giant-cell tumour of boneSophie Roux, Xavier Mariette
Blood Reviews|May 29, 2025
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapiesSophie Roux, Françoise Debiais, Marie-Hélène Vieillard
The Journal of Biological Chemistry|July 4, 2009
Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating BimNicolas Houde, Estelle Chamoux, Martine Bisson, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Revue De Synthese|August 2, 2012
[Not Available]Sophie Roux
Joint Bone Spine|February 21, 2006
RANKL inhibitors: a bright future?Sophie Roux
Joint Bone Spine|April 13, 2010
New treatment targets in osteoporosisSophie Roux
Leukemia & Lymphoma|September 14, 2004
The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expressionSophie Roux, Xavier Mariette
International Journal of Molecular Sciences|October 21, 2020
Rab GTPases in Osteoclastic Bone Resorption and AutophagyMichèle Roy, Sophie Roux
Journal of Molecular Signaling|January 6, 2012
The adaptor protein p62/SQSTM1 in osteoclast signaling pathwaysStephen McManus, Sophie Roux
Biomed Research International|September 7, 2018
Rab GTPases in Osteoclastic Endomembrane SystemsMichèle Roy, Sophie Roux
The Lancet. Oncology|June 5, 2010
RANK and RANKL expression in giant-cell tumour of boneSophie Roux, Xavier Mariette
Blood Reviews|May 29, 2025
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapiesSophie Roux, Françoise Debiais, Marie-Hélène Vieillard
The Journal of Biological Chemistry|July 4, 2009
Transforming growth factor-beta1 (TGF-beta1) induces human osteoclast apoptosis by up-regulating BimNicolas Houde, Estelle Chamoux, Martine Bisson, et al.
Pageof 5